Uzbekistan actively uses innovative surgical treatment methods

Uzbekistan actively uses innovative surgical treatment methods

Innovative treatment methods are actively employed in Uzbekistan, with more than 200 modern practices implemented at the Republican Specialized Scientific and Practical Medical Center for Surgery in Tashkent in recent years. Now, doctors are mastering another high-tech surgical technique. Thanks to the so-called PAN procedure, developed by Chinese specialists, it has become possible to treat congenital heart defects (CHD) in a modern and safe way.

«Interventional procedures are performed under X-ray guidance. Undoubtedly, this technology is minimally invasive and avoids large incisions and general anaesthesia. However, it inevitably involves exposure to X-rays, which can sometimes lead to radiation-related complications. This new technology eliminates the use of X-rays, meaning that both patients and the medical staff, who work around the clock in the interventional lab, are no longer exposed to radiation,» Sandjar Babadjanov, chief researcher of the interventional cardiology department at the Uzbekistan’s center.

The innovative method was showcased at a regional scientific symposium, where leading cardiologists from Kazakhstan, Russia, Türkiye, and Turkmenistan shared their findings on PAN procedures. Chinese specialists also conducted master classes on techniques for correcting congenital heart defects.

«The interventional method involves procedures without incisions, meaning there’s no need to stop the heart or open the chest. These operations are performed through blood vessels. As a result, it’s a minimally invasive approach, with no cutting, and most importantly, while the heart continues to beat. Naturally, the recovery time is very short – patients can usually be discharged just a day or two after surgery,» noted Serik Alimbayev, interventional cardiologist at the UMC Heart Center in Kazakhstan.

Uzbek experts note that the experience gained will enable the introduction of new technologies in the healthcare sector, as well as expand access to high-quality and safe cardiac treatment in the region.